Scintigraphic progress of the liver in a patient with Alagille syndrome (arteriohepatic dysplasia).
D016738:Alagille Syndrome / Q000175:diagnosis / Q000000981:diagnostic imaging* / Q000378:metabolism; D002648:Child; D018450:Disease Progression; D005260:Female; D006801:Humans; D007223:Infant; D008099:Liver / Q000000981:diagnostic imaging* / Q000378:metabolism; D015609:Organotechnetium Compounds / Q000493:pharmacokinetics; D011759:Pyrrolidines / Q000493:pharmacokinetics; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D013668:Technetium Tc 99m Aggregated Albumin / Q000493:pharmacokinetics; D016284:Technetium Tc 99m Pentetate / Q000493:pharmacokinetics; D013752:Tetracycline / Q000493:pharmacokinetics
D015609:Organotechnetium Compounds; D011759:Pyrrolidines; D019275:Radiopharmaceuticals; D013668:Technetium Tc 99m Aggregated Albumin; C070561:technetium Tc 99m DTPA-galactosyl-human serum albumin; C057732:technetium Tc 99m pyrrolidino-methyltetracycline; D013752:Tetracycline; D016284:Technetium Tc 99m Pentetate